Researchers at the University of Florida have developed a possible method for treating X-linked retinitis pigmentosa using gene therapy. This is the same group of researchers that developed gene therapy for Leber's Congenital Amaurosis (LCA), which is a form of retinitis pigmentosa.

They say that the LCA gene therapy "was a great advance, which showed that gene therapy is safe and lasts for years in humans, but this new study has the potential for a bigger impact, because it is treating a form of the disease that affects many more people."

To read more about gene therapy, read LCA Gene Therapy Results, and learn more about this most recent treatment development for retinitis pigmentosa here.